University of Pennsylvania's Abramson Cancer Center is attempting to address one of the most common challenges cancer patients face: Lack of transportation to critically important appointments. Now in its fifth year, the ...
Jan 5, 2024
0
0
Last month, the U.S. Food and Drug Administration (FDA) approved the use of the drug capivasertib, in combination with a current cancer treatment called fulvestrant for patients with the most common type of breast cancer, ...
Dec 21, 2023
0
0
Endometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the rise in the U.S. In 1987, there were 35,000 cases annually. That number has nearly doubled in 2023 ...
Dec 20, 2023
0
0
The p53 tumor suppressor protein is encoded by TP53, the most frequently mutated gene in cancer. A review article published in Nature Reviews Clinical Oncology by Professor Klas G Wiman and colleagues at the Department of ...
Dec 19, 2023
0
0
By harnessing unusual allies, pioneering cancer treatments could reduce the need for invasive surgery and save lives.
Dec 19, 2023
0
1
Screening for colon cancer reduces cancer rates by substantially more than previous analyses of randomized trials suggest, according to a study co-authored by an MIT economist that takes a new look at data from five trials.
Dec 19, 2023
0
38
The world's largest review on opioid medicines for cancer pain has found it is unclear whether some commonly used opioid medicines are better than a placebo and suggests that non-opioid medicines, including aspirin, may be ...
Dec 19, 2023
0
0
In a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin cancer.
Dec 18, 2023
0
0
In 2003, the first year of her fellowship in pediatric oncology, two of Giselle Saulnier Sholler's first three patients had died from neuroblastoma, closely matching the 30% survival rate expected at the time for high-risk ...
Dec 15, 2023
0
16
Resistance to therapies is one of the obstacles to overcome in cancer treatments. Understanding the mechanisms of this resistance is essential to design strategies that favor tumor cell death. A study led by the Protein Kinases ...
Dec 14, 2023
0
14
